Cargando…

Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma

This review provides a comprehensive update on emerging ROCK inhibitors as an innovative treatment option for lowering intraocular pressure (IOP) in glaucoma and aims to describe the structure, mechanism of action, pharmaceutical characteristics, desirable ocular effects, including side effects for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Humimat, Ghadeer, Marashdeh, Ibtisam, Daradkeh, Duaa, Kooner, Karanjit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921633/ https://www.ncbi.nlm.nih.gov/pubmed/33664600 http://dx.doi.org/10.2147/JEP.S259297

Ejemplares similares

Acute Bilateral Uveitis, Hypotony, and Cataracts Associated with Ipilimumab and Nivolumab Therapy: Optical Coherence Tomography Angiography Findings
por: Lee, Jessica C., et al.
Publicado: (2020)

Glaucoma Diagnosis Through the Integration of Optical Coherence Tomography/Angiography and Machine Learning Diagnostic Models
por: Kooner, Karanjit S, et al.
Publicado: (2022)

An emerging treatment option for glaucoma: Rho kinase inhibitors
por: Wang, Sean K, et al.
Publicado: (2014)

Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy
por: Wang, Jun, et al.
Publicado: (2023)

Rho-Associated Kinase Inhibitors: Potential Future Treatments for Glaucoma
por: Daneshvar, Ramin, et al.
Publicado: (2014)

Rho Kinase Inhibitors as a Neuroprotective Pharmacological Intervention for the Treatment of Glaucoma
por: Thomas, Nisha M, et al.
Publicado: (2022)

Pediatric glaucoma suspects
por: Kooner, Karanjit, et al.
Publicado: (2014)

Epidemiology and characteristics of childhood glaucoma: results from the Dallas Glaucoma Registry
por: Fung, Derrick S, et al.
Publicado: (2013)

Lifestyle Counseling for Medication Adherence in Glaucoma
por: Kim, Sandy, et al.
Publicado: (2021)

Predictors of Early Onset Glaucoma
por: Wooliscroft, Jeffrey, et al.
Publicado: (2022)

Risk factors for progression to blindness in high tension primary open angle glaucoma: Comparison of blind and nonblind subjects
por: Kooner, Karanjit S, et al.
Publicado: (2008)

A Response to the Study “Lifestyle Counseling for Medication Adherence in Glaucoma” [Response to Letter]
por: Kim, Sandy, et al.
Publicado: (2022)

Polymicrobial infection confined to Ahmed glaucoma shunt
por: Lee, Jessica C., et al.
Publicado: (2020)

Quantification of vascular morphology in optical coherence tomography angiography in primary open angle glaucoma
por: Kalva, Praneeth, et al.
Publicado: (2023)

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
por: Mateos-Olivares, Milagros, et al.
Publicado: (2021)

Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
por: Okumura, Naoki, et al.
Publicado: (2017)

Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
por: Wang, Qing, et al.
Publicado: (2022)

Intraocular Surgery in Kyphosis: An Easier Approach
por: Kooner, Karanjit S., et al.
Publicado: (2013)

Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey
por: Singh, Kirti, et al.
Publicado: (2023)

RhoA/Rho‐kinases in asthma: from pathogenesis to therapeutic targets
por: Zhang, Yan, et al.
Publicado: (2020)

The role of RhoA/Rho kinase pathway in endothelial dysfunction
por: Yao, Lin, et al.
Publicado: (2010)

RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension
por: Barman, Scott A, et al.
Publicado: (2009)

Crosstalk between Substrates and Rho-Associated Kinase Inhibitors in Cryopreservation of Tissue-Engineered Constructs
por: Bit, Arindam, et al.
Publicado: (2017)

Novel Insights into the Roles of Rho Kinase in Cancer
por: Wei, Lei, et al.
Publicado: (2016)

Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
por: Moshirfar, Majid, et al.
Publicado: (2018)

Transcorneal freezing and topical Rho-kinase inhibitor treatment in Fuchs endothelial corneal dystrophy
por: Menzel-Severing, Johannes, et al.
Publicado: (2021)

Tolerance of neurite outgrowth to Rho kinase inhibitors decreased by cyclooxygenase-2 inhibitor☆
por: Duan, Weigang, et al.
Publicado: (2012)

Training partnerships between United States and Indian eye institutions
por: Kalva, Praneeth, et al.
Publicado: (2023)

ROCK (RhoA/Rho Kinase) in Cardiovascular–Renal Pathophysiology: A Review of New Advancements
por: Seccia, Teresa M., et al.
Publicado: (2020)

Genetic Risk and Phenotype Correlation of Primary Open-Angle Glaucoma Based on Rho-Kinase Gene Polymorphisms
por: Kim, Yong-Woo, et al.
Publicado: (2021)

Investigation of Rho-Kinase Expressions and Polymorphisms in Mantle Cell Lymphoma Patients
por: Yanardağ Açık, Didar, et al.
Publicado: (2016)

RhoA/Rho kinase in spinal cord injury
por: Wu, Xiangbing, et al.
Publicado: (2016)

Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
por: Naik, Mayuresh, et al.
Publicado: (2021)

Nail-Patella Syndrome: Optical Coherence Tomography Angiography Findings
por: Zuberi, Hafsa Z., et al.
Publicado: (2022)

Rho Kinases in Embryonic Development and Stem Cell Research
por: Shi, Jianjian, et al.
Publicado: (2022)

Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
por: Chen, Wenshi, et al.
Publicado: (2020)

Rho-Associated Kinase Inhibitor Eye Drops in challenging cataract surgery
por: Antonini, Marco, et al.
Publicado: (2021)

The Regulation of Intestinal Mucosal Barrier by Myosin Light Chain Kinase/Rho Kinases
por: Jin, Younggeon, et al.
Publicado: (2020)

Peptide Substrates for Rho-Associated Kinase 2 (Rho-Kinase 2/ROCK2)
por: Kang, Jeong-Hun, et al.
Publicado: (2011)

Perioperative Use of Rho-Kinase Inhibitors has Beneficial Effect on Corneal Endothelium after Phacoemulsification
por: Alkharashi, Majed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uvsoedsrr2121gh0ms4lmtp5tu